Literature DB >> 30154636

Three-Dimensional Heart Printing for Planning of Septal Reduction Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy.

Josef Veselka1, Theodor Adla2, Radka Adlova1, Thomas Bartel3.   

Abstract

Entities:  

Year:  2018        PMID： 30154636      PMCID： PMC6103754          DOI： 10.1055/s-0038-1641751

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


× No keyword cloud information.
  4 in total

Review 1.  Medical three-dimensional printing opens up new opportunities in cardiology and cardiac surgery.

Authors:  Thomas Bartel; Andrew Rivard; Alejandro Jimenez; Carlos A Mestres; Silvana Müller
Journal:  Eur Heart J       Date:  2018-04-14       Impact factor: 29.983

2.  How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy.

Authors:  Josef Veselka
Journal:  Int J Angiol       Date:  2015-06

Review 3.  New Developments in Hypertrophic Cardiomyopathy.

Authors:  Robert M Cooper; Claire E Raphael; Max Liebregts; Nandan S Anavekar; Josef Veselka
Journal:  Can J Cardiol       Date:  2017-07-20       Impact factor: 5.223

Review 4.  Hypertrophic obstructive cardiomyopathy.

Authors:  Josef Veselka; Nandan S Anavekar; Philippe Charron
Journal:  Lancet       Date:  2016-11-30       Impact factor: 79.321
  4 in total
  1 in total

Review 1.  Three-dimensional printing for heart diseases: clinical application review.

Authors:  Yanyan Ma; Peng Ding; Lanlan Li; Yang Liu; Ping Jin; Jiayou Tang; Jian Yang
Journal:  Biodes Manuf       Date:  2021-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.